The Department of Environment has ruled that a €2.4-million expansion of the German Oncology Center (GOC) in the municipality of Amathus, Limassol, does not need a full environmental impact assessment, clearing the way for a planning permit, in a report published 16 October (Philenews).
Key takeaways
- Cyprus's Department of Environment signed off the €2.4 million German Oncology Center expansion without a full environmental impact study, published 16 October (Philenews).
- The project adds 2,560 m² of new buildings plus 1,280 m² of new roads and parking on existing car-park land in Amathus, Limassol (Philenews).
- The on-site membrane bioreactor (MBR) wastewater plant — 40 m³/day, in service since 2018 — was reviewed retroactively and tied to the same approval (Philenews).
- Radioactive liquid waste is held and rendered inert in dedicated tanks before the treated stream, which is reused only for irrigation of the centre's green areas (Philenews).
- Construction conditions include a 4 m noise barrier, controlled working hours, water spraying, an emergency holding tank and a ban on discharging sewage to ground or the storm network (Philenews).
What happened
The German Oncology Center in Amathus, Limassol, will grow by 2,560 m² of new buildings — 1,700 m² of building space plus an 850 m² basement — and 1,280 m² of new roads and parking, with the building works all sited on land already used as car parks (Philenews). The basement will take the kitchen, storage, dermatology examination rooms and the magnetic resonance imaging (MRI) suites, with seven flats for visiting specialists and relatives on the first floor, plus a 24-baby and 32-toddler nursery for staff (Philenews). The €2.4 m investment also covers a new roundabout, road widening with the Public Works Department, double glazing, energy-saving systems and use of the centre's existing 1,300 kWp photovoltaic array (Philenews).
The environmental authority bundled the on-site wastewater treatment plant into the same decision. The plant uses membrane bioreactor (MBR) technology, has a capacity of 40 m³/day and has been operating since 2018 — but no environmental study was carried out before it was built, so the authority reviewed it retrospectively, citing European Court case law and a 2022 opinion by the Attorney General (Philenews). The decision treats the plant as an exception because it is directly linked to public health and handles both sewage and radioactive liquid waste from radiotherapy; the radioactive fraction is held in special tanks, retained and rendered inert, and only then routed through the treatment plant (Philenews). Treated effluent may only be reused on the centre's green areas — discharge to ground or to the storm network is prohibited, and an emergency tank must be installed (Philenews).
Construction conditions also target nuisance for a private school 100 m away: a noise barrier of at least four metres around the site, controlled working hours and regular water spraying for dust (Philenews). The ruling effectively regularises an existing plant while setting the operating envelope for the expanded campus.
Specification read
The plant's reported duty is 40 m³/day, which converts to 0.040 megalitres per day, or roughly 220–280 population-equivalent at a typical 150–180 L per capita per day loading — well below the threshold where conventional activated-sludge basins are mandated and squarely in the packaged MBR envelope (Philenews). The treatment train reported for this duty is a single MBR line handling screened sewage plus segregated, pre-treated radioactive liquid waste, with a dedicated equalisation/emergency tank upstream, a dedicated decay/inerting tank for the hot stream, membrane separation for solids, and an irrigation-only reuse of the polished effluent (Philenews). This event bears on both the biological stage and the reuse/discharge envelope of a hospital-grade MBR; influent BOD/COD figures were not reported in the source, so any influent characterisation would have to come from the centre's own monitoring.
For procurement readers, if your plant looks like a hospital or research campus in the 20–80 m³/day band, with segregated cytotoxic or radioactive waste streams and a reuse-only effluent consent, this is the operating envelope regulators are now willing to approve retrospectively when the load is tied to public health and reuse is contained on site — which sets the precedent for how MBR duty, equalisation volume and the radioactive-waste pre-treatment step should be specified in a tender (Philenews). Where the source does not give a value — influent BOD/COD, sludge age, membrane area, emergency-tank volume — buyers should request those from the operator rather than assume them from the published scale.
Operators scoping similar small-footprint, reuse-bound hospital flows can start from the Mbr Membrane Systems catalogue and compare it with the broader Integrated Sewage Treatment range, while the Municipal hub covers the consent and reuse side of the duty.
FAQ
What capacity is the German Oncology Center's wastewater plant designed for?
The on-site MBR plant has a reported capacity of 40 m³/day and has been operating since 2018, with treated water reused only to irrigate the centre's green areas (Philenews).
How is the radioactive liquid waste from radiotherapy handled?
It is held in special tanks where it is retained and rendered inert before passing to the treatment plant, and discharge to ground or the storm network is prohibited (Philenews).
Did the regulator require a full environmental impact study for the expansion?
No. The Department of Environment ruled a full environmental impact assessment was not needed, subject to construction and operating conditions, in a decision published 16 October (Philenews).
What conditions were attached to protect the neighbouring school?
Conditions include a noise barrier at least 4 m high around the site, controlled working hours, regular water spraying for dust and an emergency holding tank (Philenews).
